Pasar al contenido principal

BLOQUEAR LA ENTRADA DE VIRUS CON ENVUELTA EN CELULAS INMUNES: NUEVOS ANTICUERPOS MONOCLONALES E INTERRUPCION DE LA CASCADA INTRACELULAR

PID2019-109870RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PRIVADA INSTITUT DE RECERCA SOBRE IMMUNOPATOLOGIES-CAIXA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses

  • Perez-Zsolt, Daniel
  • Muñoz-Basagoiti, Jordana
  • Rodón, Jordi
  • Elousa, Marc
  • Raïch-Regué, Dàlia
  • Risco, Cristina
  • Sachse, Martín
  • Pino, María
  • Gumber, Sanjeev
  • Paiardini, Mirko
  • Chojnacki, Jakub
  • Erkizia, tziar
  • Muñiz-Trabudua, Xabier
  • Ballana, Ester
  • Riveira-Muñoz, Eva
  • Noguera, Marc
  • Paredes, Roger
  • Trinité, Benjamin
  • Tarrés-Freixas, Ferrán
  • Blanco, Ignacio
  • Guallar, Victor
  • Carrillo, Jorge
  • Blanco, Julià
  • Telenti, Amalio
  • Heyn, Holger
  • Segalés, Joaquim
  • Clotet, Bonaventura
  • Martínez-Picado, Javier
  • Vergara-Alert, Júlia
  • Izquierdo-Useros, Núria
COVID-19 pandemic is not yet under control by vaccination, and effective antivirals are critical for preparedness. Here we report that macrophages and dendritic cells, key antigen presenting myeloid cells (APCs), are largely resistant to SARS-CoV-2 infection. APCs effectively captured viruses within cellular compartments that lead to antigen degradation. Macrophages sense SARS-CoV-2 and released higher levels of cytokines, including those related to cytokine storm in severe COVID-19. The sialic acid-binding Ig-like lectin 1 (Siglec-1/CD169) present on APCs, which interacts with sialylated gangliosides on membranes of retroviruses or filoviruses, also binds SARS-CoV-2 via GM1. Blockage of Siglec-1 receptors by monoclonal antibodies reduces SARS-CoV-2 uptake and transfer to susceptible target cells. APCs expressing Siglec-1 and carrying SARS-CoV-2 are found in pulmonary tissues of non-human primates. Single cell analysis reveals the in vivo induction of cytokines in those macrophages. Targeting Siglec-1 could offer cross-protection against SARS-CoV-2 and other enveloped viruses that exploit APCs for viral dissemination, including those yet to come in future outbreaks., The research of CBIG consortium (constituted by IRTA-CReSA, BSC, & IrsiCaixa) is supported by Grifols pharmaceutical. The authors also acknowledge the crowdfunding initiative #Yomecorono (https://www.yomecorono.com). J.M-P. is supported by grant PID2019-109870RB-I00 from the Spanish Ministry of Science and Innovation and in part also by Grifols. CR lab is funded by RTI2018-094445-B100 (MCIU/AEI/FEDER, UE). The authors also acknowledge the crowdfunding initiative #Yomecorono (https://www.yomecorono.com). The NHP study was primarily supported by YNPRC Coronavirus Pilot Research Project Program grant to M.Pa. under award P51 OD11132, Emergent Venture Fast grant program to MPa under awards #2206 and #2144, and William and Lula Pitts Foundation (to MPa)., No